semaglutide california banned Novo Nordisk fights to keep Medicaid paying for weight-loss drugs

📢 FDA has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the

28.08

★★★★☆4.8 (126)

It has been nearly two weeks since the semaglutide patent expired, and India's weight-loss drug market is already opening up to cheaper generics. For a country grappling with a rising obesity burden—driven

28.04

★★★★★4.9 (98)

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

27.62

★★★★★5.0 (157)

What possible compounded semaglutide ban means for patients

24.05

★★★★★4.7 (84)

A California man took in over a million dollars selling illegally imported workout supplements and prescription drugs—including semaglutide—under the label Warrior Labz:

28.47

★★★★★4.9 (203)

We're warning consumers of concerns with compounded medications containing semaglutide: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing- semaglutide-marketed-type-2-diabetes-or-weight-loss

20.38

★★★★★5.0 (176)

Ozempic copies for $14 as the generic GLP-1 era starts in India

26.85

★★★★★4.8 (132)